Bluebird Bio's Skysona (elivaldogene autotemcel;) has received Accelerated Approval from the US Food and Drug Administration (FDA). eli-cel) to slow the progression of neurologic dysfunction in early, active patients with Adrenoleukodystrophy Drugs Development Market. The treatment is demonstrated for use in young men matured four to 17 years with CALD. Through specific Qualified Treatment...